Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.14M | 783.00K | 428.00K | 139.00K | 108.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14M | 783.00K | 428.00K | 139.00K | 108.00K |
| Cost of Revenue | 497.00K | 267.00K | 25.00K | -- | -- |
| Gross Profit | 645.00K | 516.00K | 403.00K | 139.00K | 108.00K |
| SG&A Expenses | 7.67M | 7.72M | 8.92M | 8.32M | 7.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.65M | 9.45M | 10.91M | 10.29M | 9.29M |
| Operating Income | -8.51M | -8.67M | -10.48M | -10.15M | -9.18M |
| Income Before Tax | -19.88M | -21.18M | -22.83M | -22.27M | -10.46M |
| Income Tax Expenses | 5.00K | 6.00K | 6.00K | 2.00K | 2.00K |
| Earnings from Continuing Operations | -19.88 | -21.19 | -22.84 | -22.27 | -10.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.88M | -21.19M | -22.84M | -22.27M | -10.46M |
| EBIT | -8.51M | -8.67M | -10.48M | -10.15M | -9.18M |
| EBITDA | -8.41M | -8.60M | -10.45M | -10.13M | -8.08M |
| EPS Basic | -2.28 | -2.52 | -2.93 | -3.03 | -1.50 |
| Normalized Basic EPS | -1.12 | -1.22 | -1.49 | -1.55 | -0.87 |
| EPS Diluted | -2.28 | -2.52 | -2.93 | -3.03 | -1.50 |
| Normalized Diluted EPS | -1.12 | -1.22 | -1.49 | -1.55 | -0.87 |
| Average Basic Shares Outstanding | 49.73M | 44.83M | 38.41M | 30.94M | 26.17M |
| Average Diluted Shares Outstanding | 49.73M | 44.83M | 38.41M | 30.94M | 26.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |